ConductScience.org, home

Paper7686818

The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion.

Seftor RE and 3 others. Cancer Res, 1993. Cited by 160 papers, by iCite.

Cite this record

ConductScience Library. The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. Papers, record 7686818. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7686818

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion.
PubMed
Journal
Cancer Res
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
160
iCite
Relative citation ratio, by iCite
3.95
iCite
Revised in PubMed
2018-11-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Seftor RER E
2Seftor EAE A
3Stetler-Stevenson WGW G
4Hendrix MJM J

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CollagenasesMajor topic
IntegrinsMajor topic
MelanomaMajor topic
Neoplasm InvasivenessMajor topic
Receptors, CytoadhesinMajor topic
Antibodies
Humans
Matrix Metalloproteinase 9
Receptors, Fibronectin
Receptors, Vitronectin

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
NCI CA-54984NCI NIH HHSUnited StatesR03CA054984PubMed and NIHNIH RePORTER
NCI CA-59702NCI NIH HHSUnited StatesR01CA059702PubMed and NIHNIH RePORTER
R37CA059702NIHNIH RePORTER

Download CSV of grants

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.

PMIDTitleJournalYearIn PapersSource
31052560Integrins: Moonlighting Proteins in Invadosome Formation.Cancers (Basel)2019https://conductscience.org/library/papers/31052560PubMed
29097183VANGL2 interacts with integrin αv to regulate matrix metalloproteinase activity and cell adhesion to the extracellular matrix.Exp Cell Res2017https://conductscience.org/library/papers/29097183PubMed
27348267Ras-association domain family 10 acts as a novel tumor suppressor through modulating MMP2 in hepatocarcinoma.Oncogenesis2016https://conductscience.org/library/papers/27348267PubMed
26578544CD36 Is a Matrix Metalloproteinase-9 Substrate That Stimulates Neutrophil Apoptosis and Removal During Cardiac Remodeling.Circ Cardiovasc Genet2016https://conductscience.org/library/papers/26578544PubMed
24242015T11TS inhibits glioma angiogenesis by modulation of MMPs, TIMPs, with related integrin αv and TGF-β1 expressions.Tumour Biol2014https://conductscience.org/library/papers/24242015PubMed
21461859Role of DDR1 in the gelatinases secretion induced by native type IV collagen in MDA-MB-231 breast cancer cells.Clin Exp Metastasis2011https://conductscience.org/library/papers/21461859PubMed
20977885Isolation of tumorigenic circulating melanoma cells.Biochem Biophys Res Commun2010https://conductscience.org/library/papers/20977885PubMed
20470890Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.Semin Cancer Biol2010https://conductscience.org/library/papers/20470890PubMed
19400942Src, PKCalpha, and PKCdelta are required for alphavbeta3 integrin-mediated metastatic melanoma invasion.Cell Commun Signal2009https://conductscience.org/library/papers/19400942PubMed
18596065Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach.Mol Cell Proteomics2008https://conductscience.org/library/papers/18596065PubMed
18208585Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.Infect Agent Cancer2008https://conductscience.org/library/papers/18208585PubMed
18083379Angiogenesis in melanoma.Semin Oncol2007https://conductscience.org/library/papers/18083379PubMed
15116091Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis.Oncogene2004https://conductscience.org/library/papers/15116091PubMed
12856724GnT-V, macrophage and cancer metastasis: a common link.Clin Exp Metastasis2003https://conductscience.org/library/papers/12856724PubMed
12353914Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites.Mol Biotechnol2002https://conductscience.org/library/papers/12353914PubMed
11932235Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.Clin Microbiol Rev2002https://conductscience.org/library/papers/11932235PubMed
11918086An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.Clin Exp Metastasis2002https://conductscience.org/library/papers/11918086PubMed
10666376Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury.Am J Pathol2000https://conductscience.org/library/papers/10666376PubMed
10491398Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2).J Cell Biol1999https://conductscience.org/library/papers/10491398PubMed
9811334Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma.Am J Pathol1998https://conductscience.org/library/papers/9811334PubMed

See all 32 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FN12335PubTator's text mininghttps://conductscience.org/library/genes/2335NCBI Gene
IGKV4-128908PubTator's text mininghttps://conductscience.org/library/genes/28908NCBI Gene
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene
MMP94318PubTator's text mininghttps://conductscience.org/library/genes/4318NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7686818

GET https://conductscience.org/api/papers/v1/7686818/cited_by?page=2